Firstly, using a two‐stage case–control design with a total of 1818 CAD patients and 1963 controls, we found that TXNIP SNPs were significantly associated with increased CAD risk and the severity of coronary atherosclerosis in both single locus and cumulative analyses. Here, TXNIP is linked to coronary atherosclerosis.